Amnna Rashid Sheikh, PA

Amnna Sheikh practices at Stony Brook Internists in Hauppauge, New York.

Amnna Sheikh's NPI, 1932862943, was assigned on October 16, 2021. Amnna Sheikh holds New York license 027459.

Amnna Sheikh's primary practice is Stony Brook Internists, at 200 Motor Pkwy Ste C-16 Suite C-16, Hauppauge, NY 11788. The practice phone is (631) 978-7633.

Amnna Sheikh's primary practice is Stony Brook Internists in Hauppauge, New York. The medical group on file is Stony Brook Internists. Dmand AI also links Amnna Sheikh to 4 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Amnna Sheikh practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Amnna Sheikh's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Amnna Sheikh is licensed in New York.

CMS data shows 37 Medicare services from Amnna Sheikh across 1 procedure code in 2024, all of them office visits, for 43 Medicare patients. Medicare paid $3,586 for them. Every service was in an office.

CMS counts 43 Medicare patients who saw Amnna Sheikh in 2024. The largest group is 65 to 74, with 20 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Amnna Sheikh's median patient age at 50, with 68% women.

In 2024, Amnna Sheikh wrote 163 Medicare Part D claims for 64 patients. 50% of them were for generic drugs. CMS names the drug for 22 of them, across 2 drugs with 11 or more claims each, at $7,081 in total drug cost. In 2023, CMS named 767 claims across 20 drugs.

Amnna Sheikh accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 68 general payments to Amnna Sheikh from 24 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Xeris Pharmaceuticals, Inc. paid the most, $332.